[1]
Kamphuis, E. et al. 2024. Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry. Acta Dermato-Venereologica. 104, (Feb. 2024), adv19454. DOI:https://doi.org/10.2340/actadv.v104.19454.